Magnesium Sulfate Dosing in Children
For acute severe asthma or life-threatening conditions like torsades de pointes, administer 25-50 mg/kg IV/IO (maximum 2 g) over 10-30 minutes depending on the indication. 1
Clinical Context-Specific Dosing
Acute Asthma/Status Asthmaticus
- Single bolus dose: 25-50 mg/kg IV (maximum 2 g) infused over 15-30 minutes 1
- Continuous infusion (for refractory cases): Following a bolus of 25-75 mg/kg, infuse at 18.4-50 mg/kg/hour depending on severity 2
- Target serum magnesium concentration: 4-6 mg/dL 2
- This approach reduces hospital admission odds by 68% in moderate-to-severe exacerbations 3
Life-Threatening Arrhythmias
- Torsades de pointes or refractory ventricular tachycardia: 25-50 mg/kg IV/IO (maximum 2 g) 1
- Administer as rapid bolus for pulseless torsades 1
- Infuse over 10-20 minutes for torsades with pulses 1
Hypomagnesemia Treatment
- Severe hypomagnesemia: Up to 250 mg/kg IM within 4 hours if necessary 4
- Mild deficiency: Dosing extrapolated from adult regimens; use caution 4
Parenteral Nutrition (Long-term)
- Infants: 2-10 mEq (0.25-1.25 g) daily 4
- Specific recommendations reference Table 1 in ESPGHAN/ESPEN guidelines for age-specific dosing in mmol/kg/day 1
Critical Safety Considerations
Administration Guidelines
- Maximum infusion rate: Do not exceed 150 mg/minute (1.5 mL of 10% solution) except in severe eclampsia with seizures 4
- Dilution requirement: Solutions must be diluted to ≤20% concentration for IV use in children 4
- IM administration: Dilute 50% solution to ≤20% concentration before IM injection in children 4
Monitoring Requirements
- Monitor deep tendon reflexes before each dose; absent reflexes indicate toxicity 4
- Maintain urine output ≥100 mL in the 4 hours preceding each dose 4
- Monitor respiratory rate (should be ≥16 breaths/minute) 4
- Check serum magnesium concentrations regularly, especially with continuous infusions 2
Toxicity Thresholds
- Therapeutic range: 1.8-3.0 mmol/L (3-6 mg/100 mL) 5, 4
- Loss of patellar reflex: 3.5-5 mmol/L 5
- Respiratory paralysis: 5-6.5 mmol/L 5
- Cardiac conduction alterations: >7.5 mmol/L 5
- Cardiac arrest risk: >12.5 mmol/L 5
Special Populations
- Neonates exposed to maternal magnesium therapy: Limit magnesium intake and adjust based on postnatal serum concentrations due to impaired renal excretion 1
- Renal impairment: Use with extreme caution; maximum 20 g/48 hours with frequent serum monitoring 4
Common Adverse Effects
Adverse events are more common with prolonged infusions (>24 hours) and include 2:
- Hypotension (16.6% in prolonged infusions)
- Nausea/vomiting (7.8%)
- Mild muscle weakness (4.9%)
- Flushing (2.2%)
- Sedation (0.4%)
Antidote
Have calcium chloride immediately available (20 mg/kg or 0.2 mL/kg of 10% solution IV) to reverse magnesium toxicity 1, 4